Is there a role for routine screening MRI in women with LCIS?

Breast Cancer Research and Treatment

Volumn 142, Issue 2, 2013, Pages 445-453

  King, Tari A ^a   Muhsen, Shirin ^a   Patil, Sujata ^a   Koslow, Starr ^a   Oskar, Sabine ^a   Park, Anna ^a   Morrogh, Mary ^a   Sakr, Rita A ^a   Morrow, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; High risk; LCIS; MRI; Screening

Indexed keywords

ADULT; ARTICLE; BREAST EXAMINATION; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOMA IN SITU; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOBULAR CARCINOMA IN SITU; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREMENOPAUSE; PRIORITY JOURNAL; RELATIVE;

ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MIDDLE AGED; PREMENOPAUSE; TIME FACTORS;

EID: 84890390419     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2725-5     Document Type: Article

References (21)

1. Haagensen CD, Lane N, Lattes R, Bodian C (1978) Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737-769
2. Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22:1232-1239
3. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun DW Jr (1978) Lobular carcinoma in situ of the breast: detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2:225-251
4. Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A (2005) Bilateral risk for subsequent breast cancer after lobular carcinoma-in situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534-5541
5. Saslow D, Boetes C, Burke W et al (2007) American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89
6. Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437
7. Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W, Schild HH (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476
8. Lehman CD, Blume JD, Weatherall P et al (2005) Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 103:1898-1905
9. Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261:421-427
10. Port ER, Park A, Borgen PI, Morris E, Montgomery LL (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14:1051-1057
11. Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261:414-420
12. Kaas R, Muller SH, Hart AA, Rutgers EJ (2008) Stage of breast cancers found during the surveillance of women with a familial or hereditary risk. Eur J Surg Oncol 34:501-507
13. Tilanus-Linthorst MM, Obdeijn IM, Hop WC, Causer PA, Leach MO, Warner E, Pointon L, Hill K, Klijn JG, Warren RM, Gilbert FJ (2007) BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials. Clin Cancer Res 13:7357-7362
14. King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M (2012) Is there a low-grade precursor pathway in breast cancer? Ann Surg Oncol 19:1115-1121
15. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N (2004) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 100:238-244
16. Mann RM, Hoogeveen YL, Blickman JG, Boetes C (2008) MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 107:1-14
17. Gao X, Fisher SG, Emami B (2003) Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys 56:1038-1045
18. Lehman CD (2006) Role of MRI in screening women at high risk for breast cancer. J Magn Reson Imaging 24:964-970
19. Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778
20. Morris EA, Liberman L, Ballon DJ, Robson M, Abramson AF, Heerdt A, Dershaw DD (2003) MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181:619-626
21. Heijnsdijk EA, Warner E, Gilbert FJ et al (2012) Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI Screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 21:1458-1468